Bay Street News, 2018

RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company […]

Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, […]

CHARLOTTESVILLE, Va., Nov. 14, 2018 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on […]

EL SEGUNDO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ: LMRK) announced today the […]

OneSpan’s Mobile Security Suite provides frictionless, mobile authentication using biometrics and risk assessment tools to reduce fraud CHICAGO, Nov. 14, […]

TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Spectral Medical Inc., (TSX: EDT), a Phase III company developing the first treatment […]

Reports over $52 million of cash-on-hand with Company now fully funded beyond completion of the TRILOGY Phase 3 studies Both […]

TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab” or the “Company”) is a […]

LONGUEUIL, Québec, Nov. 14, 2018 (GLOBE NEWSWIRE) — Stornoway Diamond Corporation (TSX-SWY; the “Corporation” or “Stornoway”) announces that, effective January […]

LONGUEUIL, Quebec, Nov. 14, 2018 (GLOBE NEWSWIRE) — Stornoway Diamond Corporation (TSX-SWY; the “Corporation” or “Stornoway”) is pleased to report […]